“…In addition to the active constituents of garlic oil, several other natural compounds, including bromelain [ 113 ], a major protease from pineapple ( Ananas comosus ) [ 114 ], oleuropein, [ 104 ], paeoniflorin [ 115 ], a bioactive compound isolated from the dried roots of Paeonia lactifora Pallas or P. veitchii Lynch [ 115 ], the extracts from Thymus algeriensis and T. fontanesii ( Lamiaceae ) [ 116 ], quercetin [ 117 ], plumbagin [ 118 ], poly (ADP-ribose) polymerase (PARP) inhibitor 4-amino 1, 8-naphthalimide (4-ANI) [ 117 ], DOR agonist UFP-512 [ 119 ], and RTA-408 (a novel synthetic triterpenoid under clinical investigation) [ 120 ] ameliorated CCI-induced neuropathic pain. Targeted mechanisms reported involved either increasing the Nrf2 activity [ 104 , 114 , 116 , 117 , 119 , 120 ], enhancing the translocation of Nrf2 while suppressing the spinal NOD-like receptor protein 3 (NLRP3) inflammasome and NF-κB [ 115 ], or inhibiting PARP activation [ 117 ]. For example, Arruri et al reported that carvacrol attenuated CCI-induced neuropathic pain by inhibiting NLRP3 and activating autophagy via the Keap1/Nrf-2/p62 forward-feedback loop and augmenting mitochondrial quality control (MCQ) [ 121 , 122 ].…”